Aspirin irreversibly acetylates serine 529 of cyclooxygenase (COX)-1, resulting in inhibition of thromboxane A2 generation by platelets and prostacyclin by endothelial cells [1]. Because platelets lack the synthetic machinery to generate significant amounts of new COX, aspirin-induced COX-1 inhibition lasts for the lifetime of the platelet. In contrast, endothelial cells retain their capacity to generate new COX and recover normal function shortly after exposure to aspirin. Platelets have an increasingly well-defined, critical role in the acute thrombotic events associated with arterial diseases. Antiplatelet drugs have therefore assumed a major role in the therapy of these disorders [1]. Aspirin reduces the odds of an arterial...
The evidence of an incomplete inhibition of platelet function by aspirin, despite therapeutic doses ...
We tested whether cyclooxygenase 2 (COX-2) expression and unacetylated COX-1 in newly formed platele...
Platelets play a crucial role in the pathogenesis of atherosclerosis, thrombosis, and stroke. Aspiri...
Aspirin irreversibly acetylates serine 529 of cyclooxygenase (COX)-1, resulting in inhibition of thr...
Aspirin is integral to the secondary prevention of cardiovascular disease and acts to impair the dev...
Abstract: Aspirin irreversibly inhibits platelet cyclooxygenase-1 (COX-1). Aspirin resistance as def...
Aspirin, the most widely used antiplatelet agent, irreversibly acetylates the enzyme cyclooxygenase ...
Consistent levels of platelet inhibition are required to deliver effective antiplatelet therapy. Gro...
Overview analysis of indirect comparisons in clinical trials - showing saturation of the antithrombo...
Introduction: There is emerging evidence of a considerable variability of the impact of aspirin on c...
BACKGROUND: Thrombotic events still occur in aspirin-treated patients with coronary artery disease. ...
Aspirin is well recognized as an effective antiplatelet drug for secondary prevention in subjects at...
The evidence of an incomplete inhibition of platelet function by aspirin, despite therapeutic doses ...
The evidence of an incomplete inhibition of platelet function by aspirin, despite therapeutic doses ...
The evidence of an incomplete inhibition of platelet function by aspirin, despite therapeutic doses ...
The evidence of an incomplete inhibition of platelet function by aspirin, despite therapeutic doses ...
We tested whether cyclooxygenase 2 (COX-2) expression and unacetylated COX-1 in newly formed platele...
Platelets play a crucial role in the pathogenesis of atherosclerosis, thrombosis, and stroke. Aspiri...
Aspirin irreversibly acetylates serine 529 of cyclooxygenase (COX)-1, resulting in inhibition of thr...
Aspirin is integral to the secondary prevention of cardiovascular disease and acts to impair the dev...
Abstract: Aspirin irreversibly inhibits platelet cyclooxygenase-1 (COX-1). Aspirin resistance as def...
Aspirin, the most widely used antiplatelet agent, irreversibly acetylates the enzyme cyclooxygenase ...
Consistent levels of platelet inhibition are required to deliver effective antiplatelet therapy. Gro...
Overview analysis of indirect comparisons in clinical trials - showing saturation of the antithrombo...
Introduction: There is emerging evidence of a considerable variability of the impact of aspirin on c...
BACKGROUND: Thrombotic events still occur in aspirin-treated patients with coronary artery disease. ...
Aspirin is well recognized as an effective antiplatelet drug for secondary prevention in subjects at...
The evidence of an incomplete inhibition of platelet function by aspirin, despite therapeutic doses ...
The evidence of an incomplete inhibition of platelet function by aspirin, despite therapeutic doses ...
The evidence of an incomplete inhibition of platelet function by aspirin, despite therapeutic doses ...
The evidence of an incomplete inhibition of platelet function by aspirin, despite therapeutic doses ...
We tested whether cyclooxygenase 2 (COX-2) expression and unacetylated COX-1 in newly formed platele...
Platelets play a crucial role in the pathogenesis of atherosclerosis, thrombosis, and stroke. Aspiri...